MENU
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
UroGen Pharma (URGN) Ownership - Who owns UroGen Pharma?
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in innovative solutions for urothelial and specialty cancers... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
419.04M
P/E Ratio
N/A
Total Cash
249.58M
Projected Growth
N/A
Total Debt
121.92M
Revenue
89.36M
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash/Share
5.91
Total Debt/Equity
N/A
Revenue/Share
2.11 USD as % of share price
Fundamentals
URGN
Capitalization
419M
P/E Ratio
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash
250M
Total Cash/Share
5.91
Total Debt
122M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.11%
Revenue
89.4M
ROE
N/A
Book Value
25.5M
P/B Ratio
16.23
Cash Flow
N/A
Earnings
-3.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
115K
Current Ratio
9.00
Current Revenue Per Employee
116147.47
Dividends Per Share - Security
N/A
EBITDA
-97.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.27
Revenue To Assets
-46.56
Shares Held By Institutions
104M
Shares Outstanding - Current
42.2M
Total Liabilities
276M
Total Volume MTD
N/A
Value
-1
Gain YTD
-7.793
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies for urological pathologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com